Skip to main navigation
  • LogicBio Therapeutics, Inc.

Investors

  • About
  • GeneRide
  • Pipeline
  • Patient Focus
  • Investors
    • Overview
    • Press Releases
    • Events and Presentations
    • Stock Information
    • Corporate Governance
    • SEC Filings
    • Analyst Coverage
    • Investor FAQs
    • Email Alerts
    • Contact IR
    • IR Search
  • Careers
  • Contact

Investors Menu

  • Overview
  • Press Releases
  • Events and Presentations
    • Event Calendar
    • Presentations
  • Stock Information
    • Stock Chart & Quote
    • Historic Price Lookup
    • Investment Calculator
  • Corporate Governance
    • Documents & Charters
    • Management
    • Board of Directors
    • Committee Composition
  • SEC Filings
  • Analyst Coverage
  • Investor FAQs
  • Email Alerts
  • Contact IR
  • IR Search

SEC Filing Details

SEC Filing Details

Document Details

Form
4
Filing Date
Oct 25, 2018
Document Date
Oct 23, 2018
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
LogicBio Therapeutics, Inc.
Issuer
LogicBio Therapeutics, Inc.
Filer
O'Connell Daniel P

Filing Formats

View HTML
Download PDF
Download DOC
© 2019 LogicBio Therapeutics, Inc.
  • Privacy Policy
  • Contact